119th Congress · introduced in the House · Dec 11, 2025
Biological Intellectual Property Protection Act of 2025
Official title from Congress.gov
Latest action (Apr 22, 2026): Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
View on Congress.govPolicy area: International Affairs
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
Committee Consideration and Mark-up Session Held
Referred to the House Committee on Foreign Affairs.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Advanced technology and technological innovations · Asia · China · Data collection, sharing, protection · Europe · Genetics · Intellectual property · Iran · Licensing and registrations · Middle East · North Korea · Russia · Trade restrictions · Trade secrets and economic espionage
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
20 citations.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$7,040,000
Spent on own lobbying
…ion Act of 2025 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5265: USTRx Act S. 5316: Biotech Investment National Security Act (BINSA) H.R. 4780: USTRx Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$1,530,000
Spent on own lobbying
…ion Act of 2025 S. 5043: Secure Drug Supply Chain Act of 2026 S. 5265: USTRx Act S. 5316: Biotech Investment National Security Act (BINSA) H.R. 4780: USTRx Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 H.R. 9102: Biotech Investment National Security Act (BINSA) H.R. 9142: Prohibiting Adversarial Patents…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$3,150,000
Spent on own lobbying
…g Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Tariff (miscellaneous tariff bills)
$3,150,000
Spent on own lobbying
Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TWIST BIOSCIENCE CORPORATION · lobbying firm or registrant: IPOLICY SOLUTIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Trade (domestic/foreign)
$82,500
Paid to lobbying firm
H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LENOVO (UNITED STATES) INC. · lobbying firm or registrant: LENOVO (UNITED STATES) INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Trade (domestic/foreign)
$570,000
Spent on own lobbying
…trols Act of 2026; H.R. 8169, Export Control Enforcement and Enhancement Act; H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act; H.R. 6624, Biological Intellectual Property Protection Act of 2025; H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement Act (STRIDE) Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Copyright/Patent/Trademark
$2,440,000
Spent on own lobbying
…g Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Tariff (miscellaneous tariff bills)
$2,440,000
Spent on own lobbying
Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Copyright/Patent/Trademark
$7,360,000
Spent on own lobbying
…ickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket poli…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DEMAND PROGRESS ACTION, INC · lobbying firm or registrant: DEMAND PROGRESS ACTION, INC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Trade (domestic/foreign)
$70,000
Spent on own lobbying
…. 7003 BIS STRENGTH Act Export control administration H.R. 8036 Interagency Coordination in Export Controls Act of 2026 Export control interagency coordination H.R. 6624 Biological Intellectual Property Protection Act of 2025 Biotech export licensing H.R. 6996 Full AI Stack Export Promotion Act AI export policy
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FDD ACTION · lobbying firm or registrant: FDD ACTION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Banking
$240,000
Spent on own lobbying
…erous Vulnerabilities in Exports and Research to Strategic Adversaries, Regimes, and Industrial Entities of Security Concern (ADVERSARIES) Act, all provisions. H.R. 6624, Biological Intellectual Property Protection Act of 2025, all provisions. H.R. 6875, AI OVERWATCH Act, all provisions. H.R. 6996, Full AI Stack Export Promotio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LENOVO (UNITED STATES) INC. · lobbying firm or registrant: LENOVO (UNITED STATES) INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Trade (domestic/foreign)
$570,000
Spent on own lobbying
…trols Act of 2026; H.R. 8169, Export Control Enforcement and Enhancement Act; H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act; H.R. 6624, Biological Intellectual Property Protection Act of 2025; H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement Act (STRIDE) Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Copyright/Patent/Trademark
$890,000
Spent on own lobbying
…ickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket poli…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TWIST BIOSCIENCE CORPORATION · lobbying firm or registrant: IPOLICY SOLUTIONS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Trade (domestic/foreign)
$82,500
Paid to lobbying firm
H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FDD ACTION · lobbying firm or registrant: FDD ACTION
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Apr 24, 2026 · issue area: Science/Technology
$300,000
Spent on own lobbying
…efense Act of 2025, all provisions. H.R. 6275, China AI Power Report Act, all provisions. H.R. 6309, Cyber Deterrence and Response Act of 2025, all provisions. H.R. 6624, Biological Intellectual Property Protection Act of 2025, all provisions. S. 1793, COUNTER Act, all provisions. S. 2602, A bill to amend title 10, United State…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Copyright/Patent/Trademark
$2,580,000
Spent on own lobbying
…g Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Tariff (miscellaneous tariff bills)
$2,580,000
Spent on own lobbying
Issues related to tariffs Issues related to trade agreements S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LENOVO (UNITED STATES) INC. · lobbying firm or registrant: LENOVO (UNITED STATES) INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Trade (domestic/foreign)
$570,000
Spent on own lobbying
…trols Act of 2026; H.R. 8169, Export Control Enforcement and Enhancement Act; H.R. 8170, Multilateral Alignment of Technology Controls on Hardware (MATCH) Act; H.R. 6624, Biological Intellectual Property Protection Act of 2025; H.R. 6058, Semiconductor Technology Resilience, Integrity, and Defense Enhancement Act (STRIDE) Act;…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TWIST BIOSCIENCE CORPORATION · lobbying firm or registrant: IPOLICY SOLUTIONS
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 15, 2026 · issue area: Trade (domestic/foreign)
$82,500
Paid to lobbying firm
H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
TWIST BIOSCIENCE CORPORATION · lobbying firm or registrant: IPOLICY SOLUTIONS
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Trade (domestic/foreign)
$75,000
Paid to lobbying firm
H.R.6624/S.3452 - Biological Intellectual Property Protection Act of 2025 Notice of Request for Public Comments on Section 232 National Security Investigation of Import…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing